Filter & sort
The latest funding rounds from the UK tech ecosystem. Updated 4 November 2026.
Announcements
1,179
Total raised
£24.7B
disclosed amounts
This month
£9.0M
raised so far
Buoyant Ventures led the Series A round to fund international expansion and close the flood protection gap.
"This investment is an endorsement of our parametric cover and how we’re using it to solve real-world issues. The group of investors for the round couldn’t be better tailored to supporting our efforts in solving the issues around underinsurance in the face of climate change."
The extension financing was led by Parkwalk to support clinical trials for the company's knee repair technology.
"This $12.5m Series A financing round from a range of high-quality medtech investors reflects the strong progress we are making with our award-winning FibroFix product platform. FibroFix is unique in emulating the functional properties of cartilage while also facilitating rapid tissue regeneration in patients suffering the debilitating effects of serious knee cartilage injuries. With our approach, there is significant bone sparing and strong tissue integration of the implant, which will result in much faster patient recovery from surgery."
The funding round was led by MMC Ventures alongside Ataraxia, Acequia Capital, and notable angels.
"C the Signs is great for managing our cancer risk. I ran a middle-aged chap through the tool and followed the advice to order a chest x-ray and later sent a 2-week-wait referral to respiratory. It led to a lung cancer diagnosis, and he has since been operated on and doing well."
Octopus Ventures backed the London-based talent assessment software provider in a Series A round.
"I am delighted to continue our journey with Octopus Ventures which from the outset, shared our vision to help customers digitise and make fairer, more effective decisions about talent. At a time when organisations are facing significant talent challenges, whether that’s COVID, skills shortages, the impact of technology on jobs or upskilling the workforce, it’s clear that legacy approaches are no longer fit for purpose. Our enterprise assessment platform helps customers make better decisions about talent without compromising fairness, efficiency or candidate experience."
The financing was co-ordinated by WG Partners to support analytical platform expansion and new therapeutics programmes.
"The investor interest we have seen is an indication of the appetite for AI-enabled precision medicines and the innovation of our unique analytical platform for mining patient data."
